Ming-Lung Tsai
Overview
Explore the profile of Ming-Lung Tsai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsai M, Chen K, Chen P
J Am Heart Assoc
. 2025 Mar;
:e036946.
PMID: 40079336
Electronic health records (EHR) have revolutionized cardiovascular disease (CVD) research by enabling comprehensive, large-scale, and dynamic data collection. Integrating EHR data with advanced analytical methods, including artificial intelligence (AI), transforms...
2.
Chen T, Tseng C, Li Y, Lin Y, Chen D, Yang N, et al.
Acta Diabetol
. 2025 Jan;
PMID: 39812791
Purpose: Glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and basal insulin are currently used in the treatment of type 2 diabetes mellitus (T2DM) as long-acting injectables. In this study, we...
3.
Chang C, Chen C, Tsai M, Hsieh M, Chen T, Chen S, et al.
JACC Asia
. 2025 Jan;
4(12):956-968.
PMID: 39802984
Background: Few studies have incorporated echocardiography and laboratory data to predict clinical outcomes in heart failure with preserved ejection fraction (HFpEF). Objectives: This study aimed to use machine learning to...
4.
Dai J, Lin Y, Li X, Tseng C, Tsai M, Yang N, et al.
Sci Rep
. 2024 Nov;
14(1):27491.
PMID: 39528690
Given the limited head-to-head comparison of cardiovascular and renal outcomes between liraglutide and dulaglutide, our study aimed to investigate the clinical outcomes between dulaglutide and liraglutide in a real-world setting....
5.
Chou T, Lin Y, Tsai M, Tseng C, Dai J, Yang N, et al.
J Clin Gastroenterol
. 2024 Nov;
PMID: 39495818
Objective: Comparing direct oral anticoagulants (DOACs) and warfarin's efficacy and safety in patients with nonvalvular atrial fibrillation (AF) and liver cirrhosis (LC). Background: Evidence of the pharmacodynamics of DOACs is...
6.
Ho M, Chiu K, Tsai M, Yeh J, Huang Y, Li Y, et al.
J Biosci
. 2024 Oct;
49.
PMID: 39377444
The regulation of adipose tissue metabolism by irisin involves modulating gene expressions related to energy metabolism and insulin sensitivity via miRNA-mediated signaling pathways within adipose tissue. Understanding the molecular mechanisms...
7.
Chen D, Chen C, Lee C, Tseng C, Chen S, Chang S, et al.
ESC Heart Fail
. 2024 Apr;
11(4):2259-2271.
PMID: 38638078
Aims: The PIONEER-HF and PARAGLIDE-HF trials aimed to determine the efficacy and safety of the in-hospital initiation of sacubitril/valsartan in patients hospitalized for AHF. However, whether the inclusion and exclusion...
8.
Hu E, Tsai M, Lin Y, Chou T, Chen T
Medicina (Kaunas)
. 2024 Mar;
60(3).
PMID: 38541083
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used to reduce glucose levels in patients with type 2 diabetes mellitus since 2005. This meta-analysis discusses the mechanisms and potential benefits...
9.
Lu Y, Tung Y, Ho M, Yeh J, Lee C, Lee H, et al.
Vasc Endovascular Surg
. 2024 Mar;
58(6):588-594.
PMID: 38477544
Objectives: Manual compression (MC) or vascular closure devices (VCDs) are used to achieve hemostasis after percutaneous transluminal angioplasty (PTA). However, limited data on the comparative safety and effectiveness of VCDs...
10.
Tsai M, Lin Y, Chen D, Lin M, Wang C, Hsieh I, et al.
Clin Pharmacol Ther
. 2024 Feb;
116(3):747-756.
PMID: 38369974
Dual antiplatelet therapy (DAPT) with ticagrelor or adjusted-dose prasugrel has been used for acute coronary syndrome (ACS). However, few studies have directly compared these two drugs. In this study, we...